Global Sirolimus Market Companies

Pharmaceutical
Feb 2024
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Sirolimus Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in sirolimus market?

Companies such as Accord Healthcare (U.S.), Apotex Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Pfizer Inc. (U.S.), Zydus Cadila (India) and Dr. Reddy's Laboratories Ltd. (India)are major players in Sirolimus market.

Who are major players in sirolimus market?

In February 2023, Zydus Group obtained final approval from the U.S. Food and Drug Administration (FDA) for Sirolimus Tablets, 1 mg, and 2 mg (generic for Rapamune Tablets). This approval reinforced Zydus's product portfolio and market position, enabling the company to provide a vital medication for preventing organ rejection in kidney transplant recipients, enhancing affordability and access.

Which countries data is covered in the sirolimus market?

The countries covered in the sirolimus market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.